# Cerner Provides Access to De-Identified Patient Data for COVID-19 Research and Vaccine Development

- Link: https://www.widthness.com/cerner-provides-access-to-de-identified-patient-data-for-covid-19-research-and-vaccine-development/
- Published: 2020-04-25T10:15:45-05:00
- Author: Curated by Theresa Wysocki

Cerner Corporation (GLOBE NEWSWIRE) KANSAS CITY, Mo., April 24, 2020 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN), a global health care technology company, is now offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic. This offering will provide eligible health care researchers free access to Cerner’s COVID-19 data set to support epidemiological studies, clinical trials and medical treatments related to COVID-19, in line with applicable laws and guidelines. The de-identified patient data secured and stored on Cerner HealtheDataLab™, powered by Amazon Web Services Inc. (AWS), will include COVID-19-related demographics to help track spread and surge, underlying illnesses and chronic conditions, treatments, lab results and clinical complications and outcomes that could help drive important medical decisions. […] Click here to view original web page at www.bakersfield.com